119 related articles for article (PubMed ID: 1638514)
1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, E.C. 1.2.1.12.) gene expression in two malignant human mammary epithelial cell lines: BT-20 and MCF-7. Regulation of gene expression by 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3).
Desprez PY; Poujol D; Saez S
Cancer Lett; 1992 Jul; 64(3):219-24. PubMed ID: 1638514
[TBL] [Abstract][Full Text] [Related]
2. A difference in the regulation of mRNA expression between the phenotypic and the embryonic alkaline phosphatase genes in human cancer cells.
Penhallow RC; Sussman HH
Exp Cell Res; 1990 Jun; 188(2):279-85. PubMed ID: 2335189
[TBL] [Abstract][Full Text] [Related]
3. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation and renal localization of 1,25-dihydroxyvitamin D3-24-hydroxylase gene expression: effects of the Hyp mutation and 1,25-dihydroxyvitamin D3.
Roy S; Tenenhouse HS
Endocrinology; 1996 Jul; 137(7):2938-46. PubMed ID: 8770917
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray.
Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D
Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598
[TBL] [Abstract][Full Text] [Related]
6. Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3.
Akeno N; Saikatsu S; Kawane T; Horiuchi N
Endocrinology; 1997 Jun; 138(6):2233-40. PubMed ID: 9165006
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D-3 destabilizes c-myc mRNA in HL-60 leukemic cells.
Mangasarian K; Mellon WS
Biochim Biophys Acta; 1993 Feb; 1172(1-2):55-63. PubMed ID: 8439572
[TBL] [Abstract][Full Text] [Related]
8. The glyceraldehyde 3-phosphate dehydrogenase gene (GAPDH) is regulated by myeloid zinc finger 1 (MZF-1) and is induced by calcitriol.
Piszczatowski RT; Rafferty BJ; Rozado A; Tobak S; Lents NH
Biochem Biophys Res Commun; 2014 Aug; 451(1):137-41. PubMed ID: 25065746
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of 1,25-dihydroxyvitamin D3 on the glucose-6-phosphate dehydrogenase activity in the MCF-7 human breast cancer cell line.
Noun A; Garabedian M; Monet JD
Cell Biochem Funct; 1989 Jan; 7(1):1-6. PubMed ID: 2752532
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C
Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298
[TBL] [Abstract][Full Text] [Related]
11. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells--regulation by 1,25-dihydroxyvitamin D3 and selenite.
Schütze N; Fritsche J; Ebert-Dümig R; Schneider D; Köhrle J; Andreesen R; Kreutz M; Jakob F
Biofactors; 1999; 10(4):329-38. PubMed ID: 10619700
[TBL] [Abstract][Full Text] [Related]
12. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
[TBL] [Abstract][Full Text] [Related]
13. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
14. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte.
Sabath DE; Broome HE; Prystowsky MB
Gene; 1990 Jul; 91(2):185-91. PubMed ID: 2145197
[TBL] [Abstract][Full Text] [Related]
15. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D is a prooxidant in breast cancer cells.
Koren R; Hadari-Naor I; Zuck E; Rotem C; Liberman UA; Ravid A
Cancer Res; 2001 Feb; 61(4):1439-44. PubMed ID: 11245448
[TBL] [Abstract][Full Text] [Related]
17. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.
Wang DS; Yamazaki K; Nohtomi K; Shizume K; Ohsumi K; Shibuya M; Demura H; Sato K
J Bone Miner Res; 1996 Apr; 11(4):472-9. PubMed ID: 8992878
[TBL] [Abstract][Full Text] [Related]
18. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
Narvaez CJ; Welsh J
Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
[TBL] [Abstract][Full Text] [Related]
20. 1 alpha,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes.
Lomri A; Baron R
Proc Natl Acad Sci U S A; 1992 May; 89(10):4688-92. PubMed ID: 1584805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
